busulfan has been researched along with Diarrhea in 6 studies
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study compares maximal daily doses of loperamide to escalating doses of continuous intravenous (CI) octreotide acetate in bone marrow transplant (BMT) and leukemia patients." | 9.08 | Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients. ( Davidson, TG; Dix, SP; Geller, RB; Gilmore, CE; Holland, HK; Lin, LS; Topping, DL; Wingard, JR, 1995) |
| "We investigated whether adjusting the oral busulfan (BU) dosage on the basis of early pharmacokinetic data to achieve a targeted drug exposure could reduce transplant-related complications in children with advanced hematologic malignancies." | 7.70 | Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies. ( Chan, KW; Choroszy, M; Danielson, M; Felix, EA; Madden, T; Petropoulos, D; Przepiorka, D; Sprigg-Saenz, HA; Tran, HT; Worth, LL, 2000) |
| "This study compares maximal daily doses of loperamide to escalating doses of continuous intravenous (CI) octreotide acetate in bone marrow transplant (BMT) and leukemia patients." | 5.08 | Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients. ( Davidson, TG; Dix, SP; Geller, RB; Gilmore, CE; Holland, HK; Lin, LS; Topping, DL; Wingard, JR, 1995) |
| "We investigated whether adjusting the oral busulfan (BU) dosage on the basis of early pharmacokinetic data to achieve a targeted drug exposure could reduce transplant-related complications in children with advanced hematologic malignancies." | 3.70 | Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies. ( Chan, KW; Choroszy, M; Danielson, M; Felix, EA; Madden, T; Petropoulos, D; Przepiorka, D; Sprigg-Saenz, HA; Tran, HT; Worth, LL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Rix, A | 1 |
| Drude, N | 1 |
| Mrugalla, A | 1 |
| Mottaghy, FM | 1 |
| Tolba, RH | 1 |
| Kiessling, F | 1 |
| Boztug, H | 1 |
| Zecca, M | 1 |
| Sykora, KW | 1 |
| Veys, P | 1 |
| Lankester, A | 1 |
| Slatter, M | 1 |
| Skinner, R | 1 |
| Wachowiak, J | 1 |
| Pötschger, U | 1 |
| Glogova, E | 1 |
| Peters, C | 1 |
| CLIFFORD, P | 1 |
| CLIFT, RA | 1 |
| KHAN, AG | 1 |
| TIMMIS, GM | 1 |
| Geller, RB | 1 |
| Gilmore, CE | 1 |
| Dix, SP | 1 |
| Lin, LS | 1 |
| Topping, DL | 1 |
| Davidson, TG | 1 |
| Holland, HK | 1 |
| Wingard, JR | 1 |
| Tran, HT | 1 |
| Madden, T | 1 |
| Petropoulos, D | 1 |
| Worth, LL | 1 |
| Felix, EA | 1 |
| Sprigg-Saenz, HA | 1 |
| Choroszy, M | 1 |
| Danielson, M | 1 |
| Przepiorka, D | 1 |
| Chan, KW | 1 |
| Japp, H | 1 |
1 trial available for busulfan and Diarrhea
| Article | Year |
|---|---|
Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
Topics: Adult; Aged; Antidiarrheals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplanta | 1995 |
5 other studies available for busulfan and Diarrhea
| Article | Year |
|---|---|
Performance of severity parameters to detect chemotherapy-induced pain and distress in mice.
Topics: Anemia; Animals; Antineoplastic Agents; Busulfan; Cisplatin; Diarrhea; Doxorubicin; Female; Mice; Mi | 2020 |
Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Diarr | 2015 |
DIMETHYL MYLERAN THERAPY COMBINED WITH ABDOMINAL AORTIC OCCLUSION.
Topics: Adolescent; Alopecia; Aorta; Aorta, Abdominal; Busulfan; Chemotherapy, Cancer, Regional Perfusion; D | 1964 |
Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth | 2000 |
[Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
Topics: Aged; Autopsy; Biopsy; Busulfan; Diarrhea; Feeding and Eating Disorders; Female; Gastrointestinal He | 1974 |